Amnon Amit

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.8K citations

Brca1/2 Mutation, Medicine, Cancer Management +10

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 391 citations · Full text

Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal obstruction: do the benefits outweigh the risks?

Irit Chermesh, Tania Mashiach, Amnon Amit et al. · Medical Oncology · 2010 · 66 citations

Nutrition, Gastrointestinal Oncology, Incurable Patients +9

Anxiety as a Predictor of Pain Magnitude Following Termination of First-Trimester Pregnancy

Dorit Pud, Amnon Amit · Pain Medicine · 2005 · 48 citations · Full text

Implementation of a new procedure: laparoscopic versus robotic sacrocolpopexy

Nibal Awad, Suzana Mustafa, Amnon Amit et al. · Archives of Gynecology and Obstetrics · 2012 · 47 citations

Laparoscopy, Robotic Surgery, Surgery +3